Department of General Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Nephrology Department, Fundeni Clinical Institute, 022328 Bucharest, Romania.
Medicina (Kaunas). 2020 Apr 27;56(5):213. doi: 10.3390/medicina56050213.
: Pregnant women with chronic kidney disease (CKD) are at high risk of adverse maternal and fetal outcomes. Preeclampsia (PE) superimposed on CKD is estimated to occur in 21%-79% of pregnancies. Both conditions share common features such as proteinuria and hypertension, making differential diagnosis difficult. Objective: The aim of this study was to evaluate the incidence and the clinical-biological predictors of preeclampsia in pregnant women with CKD. : We retrospectively analyzed 34 pregnant women with pre-existing CKD admitted to our department between 2008 and 2017: Among the 34 patients, 19 (55.8%) developed PE and the mean time of occurrence was 31.26 ± 2.68 weeks of gestation. The median value of 24-h proteinuria at referral was 0.87 g/day (interquartile range 0.42-1.50) and 47.1% of patients had proteinuria of ≥1 g/day. Patients with PE tended to be more hypertensive, with a more decreased renal function at referral and had significantly higher proteinuria (1.30 vs 0.63 g/day, = 0.02). Cox multivariate analysis revealed that proteinuria ≥1 g/day at referral and pre-existing hypertension were independently associated with PE (adjusted hazard ratio = 4.10, 95% confidence interval: 1.52-11.02, = 0.005, adjusted hazard ratio = 2.62, 95% confidence interval: 1.01-6.77, = 0.04, respectively). The cumulative risk of PE was significantly higher in pregnant women with proteinuria ≥1 g/day at referral (log-rank, = 0.003). Proteinuria ≥ 1 g/day at referral and pre-exiting hypertension predicted PE development with accuracies of 73.5% and 64.7%, respectively. : Pregnant patients with pre-existing CKD are at high risk of developing preeclampsia, while proteinuria ≥ 1 g/day at referral and pre-existing hypertension were independent predictors of superimposed preeclampsia.
患有慢性肾脏病(CKD)的孕妇有发生不良母婴结局的高风险。估计 CKD 合并子痫前期(PE)的发生率为 21%-79%。这两种疾病都有蛋白尿和高血压等共同特征,因此鉴别诊断较为困难。目的:本研究旨在评估患有 CKD 的孕妇中 PE 的发生率和临床生物学预测因素。
我们回顾性分析了 2008 年至 2017 年间我院收治的 34 例患有 CKD 的孕妇:34 例患者中,19 例(55.8%)发生 PE,平均发病时间为 31.26±2.68 周。就诊时 24 小时尿蛋白中位数为 0.87 g/天(四分位间距 0.42-1.50),47.1%的患者蛋白尿≥1 g/天。PE 患者往往血压更高,就诊时肾功能更差,且蛋白尿显著更高(1.30 比 0.63 g/天, = 0.02)。Cox 多变量分析显示,就诊时蛋白尿≥1 g/天和既往高血压是与 PE 独立相关的因素(调整后危险比=4.10,95%置信区间:1.52-11.02, = 0.005;调整后危险比=2.62,95%置信区间:1.01-6.77, = 0.04)。就诊时蛋白尿≥1 g/天的孕妇发生 PE 的累积风险显著更高(对数秩检验, = 0.003)。就诊时蛋白尿≥1 g/天和既往高血压预测 PE 发生的准确率分别为 73.5%和 64.7%。
患有 CKD 的孕妇有发生子痫前期的高风险,而就诊时蛋白尿≥1 g/天和既往高血压是发生子痫前期的独立预测因素。